Multiplan Empreendimentos Imobiliarios SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Multiplan Empreendimentos Imobiliarios SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6036
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:建設・建築
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Multiplan Empreendimentos Imobiliarios SA – Strategy, SWOT and Corporate Finance Report
Summary

Multiplan Empreendimentos Imobiliarios SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Multiplan Empreendimentos Imobiliarios S.A. (Multiplan) develops and sells shopping malls and residential and commercial properties. The company purchases, leases and sells real estate, acquires and disposes property rights, and renders management and administrative services to its shopping malls. Multiplan operates 19 shopping malls in major markets such as Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Federal District, Alagoas, and Rio Grande do Sul. The company’s residential properties include Royal Green Peninsula, Peninsula Green, Il Villaggio, Barra Golden Green, and Chacara Santa Elena. The company also provides consulting and technical support on real estate issues. It also offers development, promotion, administration, planning and intermediation of real estate developments. Multiplan is headquartered in Rio de Janeiro, Brazil.

Scope

- Detailed information on Multiplan Empreendimentos Imobiliarios SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Multiplan Empreendimentos Imobiliarios SA in the form of a SWOT analysis
- An in-depth view of the business model of Multiplan Empreendimentos Imobiliarios SA including a breakdown and examination of key business segments
- Intelligence on Multiplan Empreendimentos Imobiliarios SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Multiplan Empreendimentos Imobiliarios SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Multiplan Empreendimentos Imobiliarios SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Multiplan Empreendimentos Imobiliarios SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Multiplan Empreendimentos Imobiliarios SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Multiplan Empreendimentos Imobiliarios SA: Company Overview 6
Multiplan Empreendimentos Imobiliarios SA: Overview and Key Facts 6
Multiplan Empreendimentos Imobiliarios SA: Overview 6
Multiplan Empreendimentos Imobiliarios SA: Key Facts 6
Multiplan Empreendimentos Imobiliarios SA: Key Employees 8
Multiplan Empreendimentos Imobiliarios SA: Major Products and Services 9
Multiplan Empreendimentos Imobiliarios SA: Company History 10
Multiplan Empreendimentos Imobiliarios SA: Management Statement 13
Multiplan Empreendimentos Imobiliarios SA: Locations and Subsidiaries 14
Multiplan Empreendimentos Imobiliarios SA: Key Competitors 15
Multiplan Empreendimentos Imobiliarios SA: Company Analysis 16
Multiplan Empreendimentos Imobiliarios SA: Business Description 16
Multiplan Empreendimentos Imobiliarios SA: SWOT Analysis 17
Multiplan Empreendimentos Imobiliarios SA: SWOT Overview 17
Multiplan Empreendimentos Imobiliarios SA: Strengths 17
Multiplan Empreendimentos Imobiliarios SA: Weaknesses 18
Multiplan Empreendimentos Imobiliarios SA: Opportunities 18
Multiplan Empreendimentos Imobiliarios SA: Threats 19
Multiplan Empreendimentos Imobiliarios SA: Recent Developments 20
Multiplan Empreendimentos Imobiliarios SA: News and Events Summary 20
Multiplan Empreendimentos Imobiliarios SA: Business Expansion 21
Multiplan Empreendimentos Imobiliarios SA: Corporate Governance 21
Multiplan Empreendimentos Imobiliarios SA: Financial Performance 21
Multiplan Empreendimentos Imobiliarios SA: Regulatory and Legal Events 22
Multiplan Empreendimentos Imobiliarios SA: Strategy and Operations 22
Appendix 24
Contact Us 24
Methodology 24
About MarketLine 25

List of Tables
Table 1: Multiplan Empreendimentos Imobiliarios SA: Key Facts
Table 2: Multiplan Empreendimentos Imobiliarios SA: Key Employees
Table 3: Multiplan Empreendimentos Imobiliarios SA: Company History
Table 4: Multiplan Empreendimentos Imobiliarios SA: Locations and Subsidiaries
Table 5: Multiplan Empreendimentos Imobiliarios SA: Key Competitors
Table 6: Multiplan Empreendimentos Imobiliarios SA: News and Events Summary
Table 7: Multiplan Empreendimentos Imobiliarios SA: Business Expansion
Table 8: Multiplan Empreendimentos Imobiliarios SA: Corporate Governance
Table 9: Multiplan Empreendimentos Imobiliarios SA: Financial Performance
Table 10: Multiplan Empreendimentos Imobiliarios SA: Regulatory and Legal Events
Table 11: Multiplan Empreendimentos Imobiliarios SA: Strategy and Operations



★海外企業調査レポート[Multiplan Empreendimentos Imobiliarios SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asarina Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB, is a sepranolone product developer. The company offers discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cyc …
  • Devon Energy Corporation:企業の戦略・SWOT・財務分析
    Devon Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Devon Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Energizer Holdings, Inc.:戦略・SWOT・企業財務分析
    Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • U.S. HealthWorks Medical Group:企業のM&A・事業提携・投資動向
    U.S. HealthWorks Medical Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's U.S. HealthWorks Medical Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務情報
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • CSL Ltd (CSL):製薬・医療:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • Perdana Petroleum Bhd (PERDANA):企業の財務・戦略的SWOT分析
    Perdana Petroleum Bhd (PERDANA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Marathon Oil Corporation:企業の戦略・SWOT・財務情報
    Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Aurora Health Care Inc:企業の戦略的SWOT分析
    Aurora Health Care Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Laissez-Faire Catering Pty Ltd:企業の戦略・SWOT・財務分析
    Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sermsuk Public Company Limited:企業の戦略・SWOT・財務分析
    Sermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products . The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It comb …
  • J. Front Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Manhattan Construction Group:企業の戦略的SWOT分析
    Manhattan Construction Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • K.P.R. Mill Ltd:企業の戦略・SWOT・財務情報
    K.P.R. Mill Ltd - Strategy, SWOT and Corporate Finance Report Summary K.P.R. Mill Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kerecis ehf:製品パイプライン分析
    Summary Kerecis ehf is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura m …
  • MDU Resources Group Inc (MDU):企業の財務・戦略的SWOT分析
    MDU Resources Group Inc (MDU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Debiopharm International SA:医療機器:M&Aディール及び事業提携情報
    Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and in-licenses promising drug candidates for developmen …
  • Eguana Technologies Inc (EGT):企業の財務・戦略的SWOT分析
    Eguana Technologies Inc (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆